DOI QR코드

DOI QR Code

Renoprotective Effect of Maydis Stigma on Puromycin Aminonucleoside-induced Nephrotic Syndrome

Puromycin Aminonucleoside에 의해 유도된 신증후군에 대한 옥미수(玉米鬚)의 보호효과

  • Yoon, Jung-Joo (Dept. of Phygiology, College of Korean Medicin) ;
  • Kho, Min-Chol (Hanbang Cardio-Renal Syndrome Research Center) ;
  • Han, Byung-Hyuk (Dept. of Phygiology, College of Korean Medicin) ;
  • Kim, Hye-Yoom (Dept. of Phygiology, College of Korean Medicin) ;
  • Ahn, You-Mee (Clinical Medicine Research Division, Korea Institute of Oriental Medicine) ;
  • Lee, Yun-Jung (Dept. of Phygiology, College of Korean Medicin) ;
  • Lee, Ho-Sub (Dept. of Phygiology, College of Korean Medicin) ;
  • Kang, Dae-Gill (Dept. of Phygiology, College of Korean Medicin)
  • 윤정주 (원광대학교 한의과대학 생리학교실) ;
  • 고민철 (원광대학교 한방심신증후군연구센터) ;
  • 한병혁 (원광대학교 한의과대학 생리학교실) ;
  • 김혜윰 (원광대학교 한의과대학 생리학교실) ;
  • 안유미 (한국한의학연구원 한의과학연구부) ;
  • 이윤정 (원광대학교 한의과대학 생리학교실) ;
  • 이호섭 (원광대학교 한의과대학 생리학교실) ;
  • 강대길 (원광대학교 한의과대학 생리학교실)
  • Received : 2021.09.03
  • Accepted : 2021.11.26
  • Published : 2021.11.26

Abstract

Objectives: Nephrotic syndrome is a kidney disorder, which is characterized by proteinuria, edema (swelling), and hyperlipidemia. Maydis Stigma (Corn silk) has been widely used in Asia as a traditional medicine and is known to have a diuretic effect and is used for the treatment of edema and indigestion. Methods: The aim of this study is to investigate the improvement effect of Maydis Stigma in treating nephrotic syndrome induced by puromycin aminonucleoside. Sprague-Dawley rats were intravenously injected with 75 mg/kg/day puromycin aminonucleoside, then treated with either Losartan or 200 mg/kg/day Maydis Stigma for seven days. Results: Maydis Stigma significantly decreased ascites and proteinuria level. Plasma levels of blood urea nitrogen (BUN) and plasma creatinine reduced significantly by Maydis Stigma. In addition, treatment with Maydis Stigma attenuated histological damage. Treatment with Maydis Stigma also restored podocin expression and reduced inflammation markers such as intracellular adhesion molecules (ICAM-1), monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor alpha (TNF-α) and high-mobility group box-1 (HMGB1). Conclusions: Maydis Stigma ameliorates kidney injury in nephrotic syndrome rat models. Maydis Stigma exerts a renoprotective effect owing to its anti-inflammatory effects and reductions of ascites and proteinuria. Thus, these results indicate that Maydis Stigma is likely to be a promising agent in the treatment of nephrotic syndrome.

Keywords

Acknowledgement

본 논문의 연구는 원광대학교(2020)의 지원을 받아 수행되었으며 이에 감사드립니다.

References

  1. Seckin I, et al. Experimentally induced puromycine aminonucleoside nephrosis (PAN) in rats: evaluation of angiogenic protein platelet-derived endothelial cell growth factor (PD-ECGF) expression in glomeruli. J Biomed Sci. 2012;19(1):24. https://doi.org/10.1186/1423-0127-19-24
  2. Orth SR, et al. The nephrotic syndrome. N Engl J Med. 1998;338(17):1202-11. https://doi.org/10.1056/NEJM199804233381707
  3. Hodson EM, et al. Corticosteriod therapy for nephrotic syndrome in children. Cochrane Database Syst Rev. 2005;1:CD001533.
  4. Bulucu F, et al. Oxidative stress status in adults with nephrotic syndrome. Clin Nephrol. 2000;53(3):169-73.
  5. Kawachi H, et al. Role of podocyte slit diaphragm as a filtration barrier. Nephrology. 2006;11(4):274-81. https://doi.org/10.1111/j.1440-1797.2006.00583.x
  6. Zhao X, et al. Kidney injury molecule-1 is upregulated in renal lipotoxicity and mediates palmitate-induced tubular cell injury and inflammatory response. Int J Mol Sci. 2019;20(14):3406. https://doi.org/10.3390/ijms20143406
  7. Hsiao WL, et al. The role of traditional Chinese herbal medicines in cancer therapy-from TCM theory to mechanistic insights. Planta Med. 2010;76(11):1118-31. https://doi.org/10.1055/s-0030-1250186
  8. Wang W, et al. Nephrotic syndrome and the TCM treatment. J Tradit Chin Med. 2004;24(3):201-3. https://doi.org/10.3969/j.issn.0255-2922.2004.03.016
  9. Kim YS, et al. Anti-inflammatory Effect of Zeae Stigma Herbal-acupuncture at KI10 on LPS-induced Nephritis in Rats. J Kor Med. 2013;34(3):143-57. https://doi.org/10.13048/jkm.13019
  10. Caceres A, et al. Diuretic activity of plants used for the treatment of urinary ailments in Guatemala. J Ethnopharmacol. 1987;19(3):233-45. https://doi.org/10.1016/0378-8741(87)90001-8
  11. Doan DD, et al. Studies on the individual and combined diuretic effects of four Vietnamese traditional herbal remedies (Zea mays, Imperata cylindrica, Plantago major and Orthosiphon stamineus). J Ethnopharmacol. 1992;36(3):225-31. https://doi.org/10.1016/0378-8741(92)90048-V
  12. Morton JF. Some folk-medicine plants of central american markets. Quart J Crude Drug Res. 1997;15:165-92. https://doi.org/10.3109/13880207709055170
  13. Shiraishi T, et al. Combination of ACE inhibitor with nicorandil provides further protection in chronic kidney disease. Am J Physiol Renal Physiol. 2014;307(12):F1313-22. https://doi.org/10.1152/ajprenal.00521.2014
  14. Sharma R, et al. Thrombin-Induced Podocyte Injury Is Protease-Activated Receptor Dependent. J Am Soc Nephrol. 2017;28(9):2618-30. https://doi.org/10.1681/ASN.2016070789
  15. Song H, et al. Glomerulosclerosis in adriamycin-induced nephrosis is accelerated by a lipid-rich diet. Pediatr Nephrol. 2000;15(3-4):196-200. https://doi.org/10.1007/s004670000464
  16. Franceschini N, et al. NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review. Genet Med. 2006;8(2):63-75. https://doi.org/10.1097/01.gim.0000200947.09626.1c
  17. Doucet A, et al. Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications. Pediatr Nephrol. 2007;22(12):1983-90. https://doi.org/10.1007/s00467-007-0521-3
  18. Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol. 2004;5(11):897-907. https://doi.org/10.1038/nrm1496
  19. Wen Y, et al. Yi Qi Qing Re Gao formula ameliorates puromycin aminonucleoside -induced nephrosis by suppressing inflammation and apoptosis. BMC Complement Altern Med. 2015;15:155. https://doi.org/10.1186/s12906-015-0673-9
  20. Erdely A, et al. Protection against puromycin aminonucleoside-induced chronic renal disease in the Wistar-Furth rat. Am J Physiol Renal Physiol. 2004;287(1):F81-9. https://doi.org/10.1152/ajprenal.00349.2003
  21. Ahmed MM, et al. Diuretic and serum electrolyte regulation potential of aqueous methanolic extract of Solanum surattense fruit validates its folkloric use in dysuria. BMC Complement Altern Med. 2016;16:166. https://doi.org/10.1186/s12906-016-1148-3
  22. Guan N, et al. Key molecular events in puromycin aminonucleoside nephrosis rats. Pathol Int. 2004;54(9):703-11. https://doi.org/10.1111/j.1440-1827.2004.01683.x
  23. Lowenborg EK. et al. Glomerular function and morphology in puromycin aminonucleoside nephropathy in rats. Nephrol Dial Transplant. 2000;15(10):1547-55. https://doi.org/10.1093/ndt/15.10.1547
  24. Coward RJ, et al. Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol. 2005;16(3):629-37. https://doi.org/10.1681/ASN.2004030172
  25. Zoja C, et al. Progression of renal injury toward interstitial inflammation and glomerular sclerosis is dependent on abnormal protein filtration. Nephrol Dial Transplant. 2015;30(5):706-12. https://doi.org/10.1093/ndt/gfu261
  26. Sanz AB, et al. Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol. 2008;19(9):1634-42. https://doi.org/10.1681/ASN.2007121336
  27. Wang Y, et al. Macrophages in renal disease. J Am Soc Nephrol. 2011;22(1):21-7. https://doi.org/10.1681/ASN.2010030269
  28. Xu X, et al. The role of determining the levels of serum collagen type IV in diagnosing early diabetic nephropathy. Ren Fail. 2002;24(6):747-53. https://doi.org/10.1081/JDI-120016063
  29. Zhu P, et al. High mobility group box 1 and kidney diseases. Int J Mol Med. 2013;31(4):763-8. https://doi.org/10.3892/ijmm.2013.1286
  30. van Beijnum JR, et al. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis. 2008;11(1):91-9. https://doi.org/10.1007/s10456-008-9093-5
  31. Zhang H, et al. High Mobility Group Box1 Inhibitor Glycyrrhizic Acid Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats. Kidney Blood Press Res. 2017;42(5):894-904. https://doi.org/10.1159/000485045
  32. Rincon J, et al. Increased oxidative stress and apoptosis in acute puromycin aminonucleoside nephrosis. Int J Exp Pathol. 2004;85(1):25-33. https://doi.org/10.1111/j.0959-9673.2004.0368.x